| Dexamethasone | Approved Investigational Vet Approved | CUL4B | 8450 |
upregulated | Dexamethasone results in increased expression of CUL4B mRNA | Xq24 | |
| Dexamethasone | Approved Investigational Vet Approved | CUL9 | 23113 |
downregulated | Dexamethasone results in decreased expression of CUL9 mRNA | 6p21.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CUTC | 51076 |
upregulated | Dexamethasone results in increased expression of CUTC mRNA | 10q24.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CXCL2 | 2920 |
downregulated | Dexamethasone results in decreased expression of CXCL2 mRNA | 4q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CXCL3 | 2921 |
downregulated | Dexamethasone results in decreased expression of CXCL3 mRNA | 4q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CXCL6 | 6372 |
downregulated | Dexamethasone results in decreased expression of CXCL6 mRNA | 4q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CXCL8 | 3576 |
downregulated | Dexamethasone results in decreased expression of CXCL8 mRNA | 4q13.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CXCR4 | 7852 |
upregulated | Dexamethasone results in increased expression of CXCR4 mRNA | 2q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CYB5A | 1528 |
upregulated | Dexamethasone results in increased expression of CYB5A mRNA | 18q22.3 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP19A1 | 1588 |
downregulated | Dexamethasone results in decreased expression of CYP19A1 mRNA | 15q21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP19A1 | 1588 |
upregulated | Dexamethasone results in increased expression of CYP19A1 mRNA | 15q21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP27A1 | 1593 |
upregulated | Dexamethasone results in increased expression of CYP27A1 mRNA | 2q35 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP2A6 | 1548 |
upregulated | Dexamethasone results in increased expression of CYP2A6 mRNA | 19q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP2B6 | 1555 |
upregulated | Dexamethasone results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP2C8 | 1558 |
upregulated | Dexamethasone results in increased expression of CYP2C8 mRNA | 10q23.33 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP2C9 | 1559 |
upregulated | Dexamethasone results in increased expression of CYP2C9 mRNA | 10q23.33 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP2S1 | 29785 |
downregulated | Dexamethasone results in decreased expression of CYP2S1 mRNA | 19q13.2 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP3A4 | 1576 |
upregulated | Dexamethasone results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP3A5 | 1577 |
upregulated | Dexamethasone results in increased expression of CYP3A5 mRNA | 7q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP3A7 | 1551 |
upregulated | Dexamethasone results in increased expression of CYP3A7 mRNA | 7q22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | CYP4Z1 | 199974 |
upregulated | Dexamethasone results in increased expression of CYP4Z1 mRNA | 1p33 | |
| Dexamethasone | Approved Investigational Vet Approved | CYTH3 | 9265 |
upregulated | Dexamethasone results in increased expression of CYTH3 mRNA | 7p22.1 | |
| Dexamethasone | Approved Investigational Vet Approved | DAAM2 | 23500 |
upregulated | Dexamethasone results in increased expression of DAAM2 mRNA | 6p21.2 | |
| Dexamethasone | Approved Investigational Vet Approved | DACT1 | 51339 |
downregulated | Dexamethasone results in decreased expression of DACT1 mRNA | 14q23.1 | |
| Dexamethasone | Approved Investigational Vet Approved | DACT3 | 147906 |
downregulated | Dexamethasone results in decreased expression of DACT3 mRNA | 19q13.32 | |